Therapeutic treatment of EAT by inducing dendritic cell
Therapeutic treatment of EAT by inducing dendritic cell
批准号:
7556367
负责人:
Bellur S Prabhakar
金额:
$36.48万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-02-01 至 2011-01-31
关键词:
Adoptive TransferAffectAntigen Presentation PathwayAntigensApoptosisApoptoticAutoimmune DiseasesAutoimmune ProcessAutoimmune ResponsesAutoimmune thyroiditisCD4 Positive T LymphocytesCell physiologyCellsClinicalColony-Stimulating FactorsDendritic CellsDendritic cell activationDevelopmentDiseaseExposure toGenerationsGranulocyte-Macrophage Colony-Stimulating FactorHashimoto DiseaseHypothyroidismImmune responseIn VitroInfiltrationInflammatoryInterferon Type IIInterleukin-10Interleukin-12Interleukin-4Knockout MiceLigandsLiteratureLymphocyteMediatingMediator of activation proteinModelingMusPathogenesisPhenotypeProductionReceptor Protein-Tyrosine KinasesRelative (related person)RoleSCID MiceSignal TransductionStagingStimulusT-Cell ActivationT-Cell ProliferationT-LymphocyteT-Lymphocyte SubsetsTestingTherapeuticThyroglobulinThyroglobulin antibodyThyroid GlandThyroiditisTumor Necrosis Factor-alphaVascular Endothelial Growth Factor Receptor-1basecytokinehuman TNF proteinin vivoinsightinterleukin-10 receptorneutralizing antibodypreventprotective effectresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Experimental Autoimmune Thyroiditis (EAT) is characterized by eventual destruction of thyroid by infiltrating
lymphocytes resulting in hypothyroidism. CD4+ T cells that produce IFN-gamma, TNF-alpha and IL-12 are
critical for the pathogenesis. In a recent study, we showed that relative to thyroglobulin (mTg) immunized
controls, mice treated with Flt3-L developed a more severe EAT characterized by massive thyroid
lymphocytic infiltration, and IL-2and IFN-gamma production. In contrast, GM-CSF treated mice failed to
develop EAT, and showed a significant increase in CD4+CD25+ regulatory T cells (Tregs). Activationof
lymphocytes from these mice with mTg in vitro yielded higher levels of IL-4 and IL-10. Neutralization of IL-10,
but not IL-4, and depletion of Tregs from these cultures restored mTg specific T cell proliferation, andIL-2
and IFN-gamma production. Further, adoptive transfer of Tregs to mTg immunized mice suppressed EAT
while, inoculation of anti-IL-10 receptor Ab reversed GM-CSF induced suppression resulting in EAT. These
results showed that suppression of EAT was mediated by Tregs most likely through enhanced production of
IL-10.
Based on these results we hypothesize that "selective activation of CD8a- dendritic cells using GM-CSF
can activate CD4+CD25+ regulatory T cells and skew ongoing anti-thyroglobulin immune responses in favor
of Th2 type, with consequent suppressive effects on the development and/or,progression of experimental
autoimmune thyroiditis." In Aim-1, efficacy of GM-CSF to confer long-term antigen specific protection upon
re-exposure to mTg will be tested. In Aim-2, we will test the ability of CD8a- and CD8a+ DCs to undergo
maturation, capture and present the antigen, and produce cytokines, and determine the mTg specific T cell
phenotype and cytokine profiles. Both DCs and T cells will be tested for their ability suppress in vitro and in
vivo mTg specific responses in WT and IL-10-/- mice. In Aim-3, we will test the effects of GM-CSF, DCs and
Tregs on the expression of MHC and B7 molecules, ARC function, and sensitivity to Fas induced apoptosis
of thyrocytes from WT and SCID mice. These studies will provide significant insights into the mode of action
of GM-CSF in suppressing EAT.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Co-targeting MADD and Wnt/β-catenin signaling in Anaplastic Thyroid Cancer
-
批准号:10618953
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Bellur S Prabhakar
-
依托单位:
Co-targeting MADD and Wnt/β-catenin signaling in Anaplastic Thyroid Cancer
-
批准号:10454759
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Bellur S Prabhakar
-
依托单位:
Co-targeting MADD and Wnt/β-catenin signaling in Anaplastic Thyroid Cancer
-
批准号:9885983
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Bellur S Prabhakar
-
依托单位:
A chimeric protein for the selective expansion of regulatory T cells
-
批准号:9141489
-
项目类别:
-
资助金额:$26.07万
-
财政年份:2016
-
负责人:Bellur S Prabhakar
-
依托单位:
Overcoming Therapeutic Resistance in Anaplastic Thyroid Cancer
-
批准号:9794741
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Bellur S Prabhakar
-
依托单位:
Overcoming Therapeutic Resistance in Anaplastic Thyroid Cancer
-
批准号:9281611
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Bellur S Prabhakar
-
依托单位:
Overcoming Therapeutic Resistance in Anaplastic Thyroid Cancer
-
批准号:8993857
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Bellur S Prabhakar
-
依托单位:
Use of Bispecific Antibody for Treating Non-obese Diabetes
-
批准号:8056696
-
项目类别:
-
资助金额:$19.27万
-
财政年份:2011
-
负责人:Bellur S Prabhakar
-
依托单位:
Characterization of therapeutic human monoclonal antibodies against SARS
-
批准号:7929502
-
项目类别:
-
资助金额:$47.32万
-
财政年份:2009
-
负责人:Bellur S Prabhakar
-
依托单位:
Characterization of therapeutic human monoclonal antibodies against SARS
-
批准号:7645228
-
项目类别:
-
资助金额:$56.92万
-
财政年份:2009
-
负责人:Bellur S Prabhakar
-
依托单位:
Therapeutic treatment of EAT by inducing dendritic cell
-
批准号:7340389
-
项目类别:
-
资助金额:$36.48万
-
财政年份:2006
-
负责人:Bellur S Prabhakar
-
依托单位:
Therapeutic treatment of EAT by inducing dendritic cell
-
批准号:7755035
-
项目类别:
-
资助金额:$36.12万
-
财政年份:2006
-
负责人:Bellur S Prabhakar
-
依托单位:
Therapeutic treatment of EAT by inducing dendritic cell
-
批准号:7173295
-
项目类别:
-
资助金额:$37.19万
-
财政年份:2006
-
负责人:Bellur S Prabhakar
-
依托单位:
Therapeutic treatment of EAT by inducing dendritic cell
-
批准号:7037820
-
项目类别:
-
资助金额:$38.3万
-
财政年份:2006
-
负责人:Bellur S Prabhakar
-
依托单位:
Novel human gene-IG20-potential role in cancer therapy
-
批准号:7066105
-
项目类别:
-
资助金额:$26.9万
-
财政年份:2005
-
负责人:Bellur S Prabhakar
-
依托单位:
Novel human gene-IG20-potential role in cancer therapy
-
批准号:7612142
-
项目类别:
-
资助金额:$26.12万
-
财政年份:2005
-
负责人:Bellur S Prabhakar
-
依托单位:
Novel human gene-IG20-potential role in cancer therapy
-
批准号:7234289
-
项目类别:
-
资助金额:$26.12万
-
财政年份:2005
-
负责人:Bellur S Prabhakar
-
依托单位:
Novel human gene-IG20-potential role in cancer therapy
-
批准号:6989387
-
项目类别:
-
资助金额:$27.55万
-
财政年份:2005
-
负责人:Bellur S Prabhakar
-
依托单位:
Novel human gene-IG20-potential role in cancer therapy
-
批准号:7428820
-
项目类别:
-
资助金额:$26.12万
-
财政年份:2005
-
负责人:Bellur S Prabhakar
-
依托单位:
Induction of tolerance to islet cell transplants
-
批准号:6730220
-
项目类别:
-
资助金额:$31.03万
-
财政年份:2003
-
负责人:Bellur S Prabhakar
-
依托单位:
海外基金